Reneo Pharmaceuticals (RPHM) Financials

$1.81

up-down-arrow $-15.49 (-89.54%)

As on 04-Oct-2024 18:32EDT

Market cap

info icon

$61 Mln

Revenue (TTM)

info icon

$1 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.8

Div. Yield

info icon

0 %

Income Statement ($ Mln)

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Operating Revenue
1.47
--
--
--
--
--
Cost of Revenue
0.12
0.53
0.53
0.05
0.04
0.03
Gross Profit
0.62
-0.53
-0.53
-0.05
-0.04
-0.03
Operating Expenses
62.81
83.05
53.85
39.82
19.55
15.47
Operating Profit (EBIT)
-62.88
-83.05
-53.85
-39.82
-19.55
-15.47
Other Income
--
--
1.89
--
--
--
Profit before Tax
-56.54
-77.39
-51.96
-39.77
-19.47
-12.44
Provision for Tax
0.99
0.65
-1.89
-0.19
-0.17
-3.04
Profit after Tax (Net Income)
-56.54
-77.39
-50.06
-39.77
-19.47
-12.44
Minority Interest
--
--
--
--
--
--
Consolidated Profit
--
--
-51.96
-39.77
-19.47
-12.44

Liabilities ($ Mln)

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Shareholder's Funds
76.87
88.61
99.97
147.21
-42.12
-23.13
Minority Interest
--
--
--
--
--
--
Non-Current Liabilities
0.50
0.65
1.09
0.61
92.76
45.69
Current Liabilities
1.35
18.18
7.12
6.20
4.58
2.94
Total Liabilities
80.07
107.44
108.18
154.02
55.22
25.51

Assets ($ Mln)

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Non-Current Assets
0.73
0.81
1.83
0.29
0.20
0.10
Current Assets
77.99
106.62
106.35
153.73
55.03
25.41
Total Assets
80.07
107.44
108.18
154.02
55.22
25.51
Total Debt*
0.82
0.97
1.46
--
92.72
45.65
Net Current Assets
76.64
88.45
99.23
147.53
50.45
22.47

Cashflow ($ Mln)

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Cash From Operating Activities
--
-63.68
-47.36
-37.98
-18.54
-12.51
Cash Flow from Investing Activities
--
--
-57.84
-23.38
7.38
-7.24
Cash from Financing Activities
--
60.87
0.47
132.41
47.27
24.99
Net Cash Inflow / Outflow
--
--
-104.73
--
--
--

Financials Ratios

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Adjusted EPS ($) info
--
--
--
--
--
--
Cash EPS ($) info
--
--
--
--
--
--
Adjusted Book Value ($) info
--
--
--
--
--
--
Dividend per Share ($) info
--
--
--
--
--
--
Cash Flow per Share ($) info
--
--
--
--
--
--
Free Cash Flow per Share ($) info
--
--
--
--
--
--

Profitability Ratios

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
ROCE (%) info
--
-81.03
-40.27
-40.21
-53.23
--
ROE (%) info
-68.33
-82.07
-40.51
-75.68
59.67
--
ROA (%) info
-46.76
-71.78
-38.19
-38.01
-48.22
--
EBIT Margin (%) info
-4,286.57
--
--
--
--
--
Net Margin (%) info
-3,851.29
--
-2,644.59
--
--
--
Cash Profit Margin (%) info
-0.03
--
--
--
--
--

Growth Ratios

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Revenue Growth (%) info
--
--
--
--
--
--
EBIT Growth (%) info
4.18
-51.79
-36.34
-103.65
-26.36
--
Net Profit Growth (%) info
3.25
-54.58
-25.88
-104.32
-56.52
--
EPS Growth (%) info
--
--
--
--
--
--
Book Value Growth (%) info
--
--
--
--
--
--

Valuation Ratios

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Price / Earnings info
--
--
--
--
--
--
Price / Book Value info
0.79
--
--
--
--
--
Dividend Yield (%) info
--
--
--
--
--
--
EV/EBITDA info
0.16
1.24
1.85
3.71
--
--
Close Price ($) info
15.10
16.00
23.30
85.50
--
--
High Price ($) info
92.10
112.95
95.98
171.80
--
--
Low Price ($) info
9.80
9.80
17.90
59.50
--
--
Market Cap ($ Cr) info
60.84
--
--
--
--
--

Solvency Ratios

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Debt to Equity info
--
0.01
0.01
--
-2.20
-1.97
Short term debt to equity ratio info
0.00
0.00
0.00
--
--
--
Current Ratio info
57.86
5.87
14.93
24.79
12.01
8.64
Quick Ratio info
57.86
--
--
--
--
--
Interest Coverage info
-26.82
--
-28.68
-829.54
--
--

Operating Efficiency Ratios

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Debtors to sales (%) info
--
--
--
--
--
--
Asset Turnover info
0.01
--
--
--
--
--
Receivable days info
--
--
--
--
--
--
Inventory Days info
--
--
--
--
--
--
Payable days info
--
3,690.76
1,351.56
10,701.83
7,156.93
5,822.51
Cash Conversion Cycle info
--
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...